Fact CheckerSign in

NCT06290427Recruiting

Comparison of Outcomes of Multiple Platforms for Assisted Robotic-Kidney (COMPAR-K)

Comparison of Outcomes of Multiple Platforms for Assisted Robotic-Kidney

Source: ClinicalTrials.gov · Last updated 3 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The Urology Unit of AOUI Verona proposes a clinical study aimed at a preliminary evaluation of postoperative complications specifically focused on robotic partial nephrectomy (RAPN) procedures using two currently available platforms: * DaVinci®; * Hugo®. The questions it aims to answer are: Does the estimation of the post-operative complications suggest something? Are differences (intra- and post-operative, oncological, functional, technical, and economic) among the three intervention approaches observable? Participants will be invited to join one of these two experimental group: 1. surgery with the DaVinci platform; 2. surgery with the Hugo platform.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
30 (estimated)
First submitted
21 Feb 2024
Start date
1 Feb 2024
Primary completion date
12 Dec 2024
Lead sponsor
Azienda Ospedaliera Universitaria Integrata Verona
NCT number
NCT06290427

What you commit to

  • Study type: Interventional
  • Planned participants: 30
  • From 1 Feb 2024 to the primary completion date, 12 Dec 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Age

  • patient who do not fall within the inclusion age range;

Other

  • patient not suitable for partial nephrectomy;
  • patient unable to understand and sign the informed consent;
  • patient unable to follow the monitoring program;
  • patient refusal to participate to the study.

Who the study is looking for

  • patient aged between 18 and 90 years old;
  • patient with localized kidney tumor suitable for partial nephrectomy;
  • patient able to understand and sign the informed consent;
  • patient compliance with the follow-up program.

Age in the registry: 18 years to 90 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Urology Unit, AOUI Verona
Coordinator of this site? Confirm its status
VeronaItalyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.